Ƶ

The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again

— News and commentary from the world of neurology and neuroscience

Ƶ MedicalToday
Neuro Break over a computer rendering of neurons.

New research about the dying brain suggested the may not be distinct. (The Guardian)

A single fecal microbiota transplantation induced mild but sustained in early Parkinson's disease. (eClinical Medicine)

A new California bill aimed to , which has been tied to Parkinson's risk. (Mother Jones)

An analysis using data from the FDA's Adverse Event Reporting System suggested a possible link between anti-diabetic and multiple sclerosis. (Therapeutic Advances in Neurological Disorders)

Prophylactic seizure treatment after mild and moderate traumatic brain injury was associated with a small reduced risk of early . (JAMA Neurology)

Targeting KCNJ2 may after brain injury, a study in mice and brain organoids suggested. (Cell Stem Cell)

The NFL and its players' association approved eight new to help reduce head impact. (AP)

BrainStorm Cell Therapeutics said the FDA agreed to a protocol for a phase IIIb trial of investigational for amyotrophic lateral sclerosis (ALS). Last year, FDA advisors overwhelmingly rejected the treatment based on phase III study results.

The brain-computer interface (BCI) company Synchron announced the launch of a and is preparing to recruit patients for a . (Reuters)

Epilepsy patients benefited from structured , new research showed. (Neurology Clinical Practice)

The Wall Street Journal looked at what people can do in midlife to future dementia.

  • Judy George covers neurology and neuroscience news for Ƶ, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.